|
Norte-Munoz M, Portela-Lomba M, Sobrado-Calvo P, Simon D, Di Pierdomenico J, Gallego-Ortega A, Perez M, Cabrera-Maqueda JM, Sierra J, Vidal-Sanz M, Moreno-Flores MT, Agudo-Barriuso M. Differential response of injured and healthy retinas to syngeneic and allogeneic transplantation of a clonal cell line of immortalized olfactory ensheathing glia: a double-edged sword. Neural Regen Res. 2025 Aug 1;20(8):2395-2407. doi: 10.4103/NRR.NRR-D-23-01631. Epub 2024 May 13. PubMed PMID: 39359096; PubMed Central PMCID: PMC11759016.
AÑO: 2025; IF: 6.7
|
39359096
|
Rodriguez-Ramirez KT, Galindo-Romero C, Lucas-Ruiz F, Vidal-Sanz M, Agudo-Barriuso M. Neuroprotection of retinal ganglion cells by agonism of the beta but not the alpha oestrogen receptor in the axotomized retina of male and female mice. Acta Ophthalmol. 2025 Aug;103(5):571-579. doi: 10.1111/aos.17454. Epub 2025 Feb 7. PubMed PMID: 39916676.
AÑO: 2025; IF: 2.8
|
|
Lucas-Ruiz F, Fernandez-Nogales M, Valiente-Soriano FJ, Herrera M, Nadal-Nicolas FM, Agudo-Barriuso M, Herrera E. Restorative potential of ciliary body cells in a retinal ganglion cell degeneration model. Sci Rep. 2025 May 3;15(1):15503. doi: 10.1038/s41598-025-00283-0. PubMed PMID: 40319064; PubMed Central PMCID: PMC12049432.
AÑO: 2025; IF: 3.9
|
|
Norte-Munoz M, Garcia-Bernal D, Garcia-Ayuso D, Vidal-Sanz M, Agudo-Barriuso M. Interplay between mesenchymal stromal cells and the immune system after transplantation: implications for advanced cell therapy in the retina. Neural Regen Res. 2024 Mar;19(3):542-547. doi: 10.4103/1673-5374.380876. PubMed PMID: 37721282; PubMed Central PMCID: PMC10581591.
AÑO: 2024; IF: 6.7
|
|
Gramignoli R, Hofmann N, Agudo-Barriuso M, Antica M, Flores AI, Girandon L, Kerdjoudj H, Navakauskiene R, Schiavi J, Scholz H, Shablii V, Lafarge X, Nicolas FJ, Gindraux F. Expert Revision of Key Elements for Clinical-Grade Production and Qualification of Perinatal Derivatives. Stem Cells Transl Med. 2024 Jan 12;13(1):14-29. doi: 10.1093/stcltm/szad068. PubMed PMID: 38071447; PubMed Central PMCID: PMC10785218.
AÑO: 2024; IF: 4.9
|